Open Label Study of mRNA-3927 in Patients With Propionic Acidemia
Learn more about:
Related Clinical Trial
A Retrospective Study to Characterize Participants With Propionic Acidemia
Natural History Study of Patients With Methylmalonic Acidemia and Propionic Acidemia
Characterization of Intestinal Microbiota in Children With Inborn Errors of Metabolism (IEM)
A Long-Term Extension Study to Evaluate the Safety and Clinical Activity of mRNA-3927
A First in Human, Dose Escalation Study to Evaluate the Safety and Tolerability of BBP-671 in Healthy Volunteers and Patients With Propionic Acidemia or Methylmalonic Acidemia
Study of HST5040 in Subjects With Propionic or Methylmalonic Acidemia
Review of Charts From Amish/Mennonite Variant PA Patients
“The MaP Study”: Mapping the Patient Journey in MMA and PA
Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach
Increasing Ureagenesis in Inborn Errors of Metabolism With N-Carbamylglutamate
Open Label Study of mRNA-3927 in Patients With Propionic Acidemia
Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia
Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia
Anaplerotic Therapy in Propionic Acidemia
Carglumic Acid in Methylmalonic Acidemia and Propionic Acidemia